Skip Navigation

A Phase I Multiple Dose Study to Evaluate the Safety and Tolerability of XmAb�20717 in Subjects with Selected Advanced Solid Tumors DUET-2

Brief Summary

Type:
Other

Study Type:
Treatment

Phase:
I

ClinicalTrials.gov Identifier:
NCT03517488

Study #:
STUDY00142507

Start Date:
Nov 08, 2018

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT03517488

View Complete Trial Details & Eligibility at ClinicalTrials.gov